Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1971 May 22;2(5759):440–442. doi: 10.1136/bmj.2.5759.440

Use of Glucagon in the Treatment of Pancreatitis

Michael J Knight, John R Condon, Rodney Smith
PMCID: PMC1796215  PMID: 5576005

Abstract

Four patients with pancreatic disease received glucagon intravenously. In two a definite decrease in the volume of pancreatic exocrine secretion was shown, and in one of these pancreatic juice protein and bicarbonate levels also fell. Two patients with acute pancreatitis had pronounced relief of epigastric pain associated with falls in plasma amylase after intravenous glucagon.

Several mechanisms could account for the possible beneficial effect of glucagon in pancreatitis, and further studies of its use in this disease are justified.

Full text

PDF
440

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brogan E., Kozonis M. C., Overy D. C. Glucagon therapy in heart-failure. Lancet. 1969 Mar 8;1(7593):482–484. doi: 10.1016/s0140-6736(69)91587-6. [DOI] [PubMed] [Google Scholar]
  2. DREILING D. A., JANOWITZ H. D. The effect of glucagon on gastric secretion in man. Gastroenterology. 1959 May;36(5):580–581. [PubMed] [Google Scholar]
  3. Dyck W. P., Rudick J., Hoexter B., Janowitz H. D. Influence of glucagon on pancreatic exocrine secretion. Gastroenterology. 1969 Mar;56(3):531–537. [PubMed] [Google Scholar]
  4. Dyck W. P., Texter E. C., Jr, Lasater J. M., Hightower N. C., Jr Influence of glucagon on pancreatic exocrine secretion in man. Gastroenterology. 1970 Apr;58(4):532–539. [PubMed] [Google Scholar]
  5. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  6. Lawrence A. M. Radioimmunoassayable glucagon levels in man: effects of starvation, hypoglycemia, and glucose administration. Proc Natl Acad Sci U S A. 1966 Feb;55(2):316–320. doi: 10.1073/pnas.55.2.316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Nakajima S., Magee D. F. Inhibition of exocrine pancreatic secretion by glucagon and D-glucose given intravenously. Can J Physiol Pharmacol. 1970 May;48(5):299–305. doi: 10.1139/y70-049. [DOI] [PubMed] [Google Scholar]
  8. POLLOCK A. V. Acute pancreatitis; analysis of 100 patients. Br Med J. 1959 Jan 3;1(5113):6–14. doi: 10.1136/bmj.1.5113.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Paloyan D., Paloyan E., Worobec R., Ernst K., Deininger E., Harper P. V. Serum glucagon levels in experimental acute pancreatitis in the dog. Surg Forum. 1966;17:348–349. [PubMed] [Google Scholar]
  10. Quirarte C., Woodward E. R., Dragstedt L. R. Glucagon and inhibition of gastric secretion. Arch Surg. 1966 Sep;93(3):475–479. doi: 10.1001/archsurg.1966.01330030105021. [DOI] [PubMed] [Google Scholar]
  11. STUNKARD A. J., VAN ITALLIE T. B., REIS B. B. The mechanism of satiety: effect of glucagon on gastric hunger contractions in man. Proc Soc Exp Biol Med. 1955 Jun;89(2):258–261. doi: 10.3181/00379727-89-21776. [DOI] [PubMed] [Google Scholar]
  12. Trapnell J. E. The natural history and prognosis of acute pancreatitis. Ann R Coll Surg Engl. 1966 May;38(5):265–287. [PMC free article] [PubMed] [Google Scholar]
  13. Unger R. H., Ketterer H., Dupré J., Eisentraut A. M. The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs. J Clin Invest. 1967 Apr;46(4):630–645. doi: 10.1172/JCI105565. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES